Shares of micro-cap Obalon Therapeutics Inc OBLN traded higher Tuesday after the company announced it has obtained two new U.S. patents covering its proprietary intragastric balloon system.
The Obalon balloon system is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity.
Obalon Therapeutics shares were trading higher by 4.27% at 64 cents at the time of publication Tuesday.
Related Links:
Obalon Ticks Higher Amid Patent Abstract For Intragastric Device
Premarket Approval Doc For Balloon System Sends Obalon Shares Sharply Higher
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
